← Evidence map

TrialCritical care (London, England)2014

Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.

Michael Behnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

90 papers cite itlatest 60 shown

2014
…
2015
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 25190134